Health

According to the Parkinson’s Foundation, a new study estimates that nearly 90,000 people in the U.S. are diagnosed with Parkinson’s disease each year. This represents a steep 50% increase from the previous estimate of 60,000 diagnoses per year. Johns Hopkins neurologist Liana Rosenthal reveals what is behind this increase as well as other important information from Parkinson’s disease research.

Research has shown that clinical use of psilocybin can be a beneficial tool for mental health professionals in treating a variety of mental health conditions such as treatment resistant depression, end of life distress, as well as substance use disorders. Join Johns Hopkins psychiatrist Mary "Bit" Yaden as she provides an update on the use of psilocybin in research and clinical settings.

Hormone changes during pregnancy can profoundly affect the mother’s mood, including long after delivery. Learn about the causes of post-partum depression when from national chair Kelly Ripen speaks with psychiatrist Lindsay Standeven, clinical and education director for the Johns Hopkins Reproductive Mental Health Center.

Every woman will eventually go through menopause and while each woman's experience is unique, there is some unique experiences that unite women of color during perimenopause through post-menopause. 

Special guest moderator for this podcast is psychiatrist Erica Richards, who serves as Chair and Medical Director in the Department of Psychiatry and Behavioral Health at Sibley Memorial Hospital.  Dr. Richards sits down to discuss what women of color need to know about menopause with associate professor of gynecology and obstetrics, Dr. Wen Shen, who serves as director of the Women's Wellness & Healthy Aging Program at Johns Hopkins.

With over 100 autoimmune disease affecting 23.5 million Americans and nearly 80% of those being women, moderator Lillie Shockney is joined by Dr. Julie Paik, assistant professor of medicine and the director of Clinical Trials at the Johns Hopkins Myositis Center to discuss autoimmune diseases in women.

As baby boomers grow older, the World Health Organization projects that by 2060, 95 million people will be age 65 or older.

Lillie Shockney was joined by geriatrician and researcher Peter Abadir, an associate professor of medicine at the Johns Hopkins University School of Medicine to discuss aging well, especially the role that our DNA plays in the development of chronic inflammation.

COVID first brought to global attention that our ability to smell could be affected by disease. Moderator Lillie Shockney sat down with  otolaryngologist and clinic director of Otolaryngology–Head and Neck Surgery at the Johns Hopkins Health Care & Surgery Center – Green Spring Station, Dr. Nicholas Rowan, to discuss anosmia,  which is the partial or complete loss of the sense of smell.